This article was originally published in The Gray Sheet
The Jan. 14, 2008 issue (1back page) erroneously reported that Arkansas surgeon Patrick Chan pled guilty Jan. 3 to receiving illegal kickbacks from Synthes and Blackstone Medical (now part of Orthofix). In fact, Chan pled guilty to receiving illegal kickbacks from a distributor of spine surgery devices made by Osteotech, Orthofix, Alphatec and Signus. Chan's agreement to pay $1.5 million to settle a whistleblower's allegations that he took illegal kickbacks from Synthes and Blackstone is part of a separate civil case, in which he admitted no wrongdoing
You may also be interested in...
Arkansas surgeon Patrick Chan pleads guilty Jan. 3 to receiving illegal kickbacks from orthopedic device-makers Synthes and Blackstone Medical, which was acquired by Orthofix in 2006 (1"The Gray Sheet" Aug. 6, 2007, In Brief). Chan has also entered into a $1.5 million civil settlement with the U.S. government, the State of Arkansas and the "whistle-blower," an orthopedic device salesman who brought the case, in which Blackstone and Synthes are co-defendants, to the government's attention in 2006. Because Chan is expected to leave the country once sentenced, the prosecuting attorney filed a petition with the court Jan. 7 to first subpoena and depose him, since "Chan still has critical evidence on his remaining co-defendants' scheme to induce Chan and other surgeons to use the defendants' surgical products by paying them kickbacks under the guise of consulting agreements and similar arrangements.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.